Looking at AI agents by industry in 2026 — across healthcare, finance, legal, sales, and engineering — patterns emerge in where adoption is real and where it stalls. Headline finding: AI agents are landing first in sectors where work is repetitive, digitally observable, and tied to a clear business outcome. In healthcare, finance, legal, sales, and engineering, the strongest early deployments are not fully autonomous coworkers but workflow-specific systems that handle calls, documentation, research, drafting, prospecting, and coding with human review still in the loop. The sector data also shows a capital concentration around agent infrastructure and application-layer companies, with engineering and sales producing the most visible product adoption while healthcare and legal face heavier trust, compliance, and workflow-integration constraints.
The headline chart: five sectors, one pattern
5
sectors analyzed
Healthcare, finance, legal, sales, and engineering
$8.2B
AI agent startup funding
Raised since 2023, per CB Insights in April 2025
Enterprise apps
lead category
Largest share of agent startup funding and deals in CB Insights’ April 2025 analysis
Lead category: engineering and developer tools
Across healthcare, finance, legal, sales, and engineering, AI agents are being adopted where tasks are high-frequency, text-heavy, and easy to benchmark. That pattern is visible in the products companies are actually shipping: healthcare voice and documentation systems such as Hippocratic AI and Abridge; finance research and operations tools such as Hebbia and Endex; legal drafting and review products such as Harvey, Robin AI, and EvenUp; sales automation vendors such as 11x, Artisan, and Clay; and engineering products such as Cognition and Cursor from Anysphere.
The common denominator is not full autonomy. It is constrained execution inside an existing workflow. In healthcare, that means patient communication and ambient documentation. In finance, it means research, search, and analyst-style synthesis. In legal, it means contract review and claims support. In sales, it means outbound sequencing and account research. In engineering, it means code generation, editing, debugging, and task execution inside familiar developer tools.
The funding backdrop helps explain why these sectors are crowded. CB Insights said in April 2025 that AI agent startups had raised $8.2 billion since 2023, with enterprise applications accounting for the largest share of deals and funding among agent startups in its dataset. That does not tell us which vertical wins long term, but it does show where capital has already decided the near-term market is real.
📌 What the data says. The strongest early agent markets are workflow markets. Buyers are paying for agents that reduce handle time, drafting time, research time, or coding time—not for open-ended autonomy.
“The sectors moving fastest are the ones where an agent can be judged against a queue, a draft, a ticket, or a code diff.”
alatirok analysis based on company materials and reported funding/adoption data
| Sector | Named companies | What agents are doing now | What appears to be working | What is still hard |
|---|---|---|---|---|
| Healthcare | Hippocratic AI, Abridge | Patient calls, care navigation, ambient documentation | Narrow workflows with clear guardrails and human oversight | Clinical trust, safety validation, EHR integration |
| Finance | Hebbia, Endex | Research, diligence, search, back-office workflows | Document-heavy analysis and analyst productivity | Auditability, data permissions, model reliability |
| Legal | Harvey, Robin AI, EvenUp | Contract review, drafting, claims and case preparation | High-volume text workflows with review loops | Hallucination risk, privilege, accuracy expectations |
| Sales | 11x, Artisan, Clay | Outbound, prospecting, enrichment, personalization | Top-of-funnel automation and workflow orchestration | Message quality, deliverability, compliance, saturation |
| Engineering | Cognition Devin, Cursor, Anysphere | Coding, debugging, codebase navigation, task execution | Immediate developer feedback loops and measurable output | Reliability on long tasks, security, production readiness |
Healthcare: agents are landing in calls and clinical documentation
Healthcare verdict: strong wedge, narrow scope
Healthcare is one of the most promising and most constrained sectors for agents. The work is repetitive and expensive, but the tolerance for error is low. That is why the most credible deployments are narrow. Hippocratic AI positions its product around patient-facing, non-diagnostic clinical tasks such as outreach and care operations, while Abridge focuses on ambient clinical documentation and note generation from medical conversations.
The funding data shows why the category has drawn attention. In January 2024, Hippocratic AI announced a $53 million Series A led by Premji Invest and General Catalyst. In January 2025, the company announced a $141 million Series B at a $1.64 billion valuation. Abridge announced a $150 million Series C in February 2025. Those are large rounds for products aimed at very specific healthcare workflows, which suggests investors see workflow-level deployment, not general-purpose medical autonomy, as the commercial wedge.
What appears to be working is the pairing of voice AI with tightly scoped operational tasks. Abridge says its platform is used to generate clinical notes from conversations and integrates with major EHR systems including Epic. Hippocratic AI emphasizes safety architecture and non-diagnostic use cases. That framing matters because healthcare buyers need evidence of guardrails, auditability, and workflow fit before they will trust an agent in production.
What is not solved is broad autonomous clinical reasoning. The public materials from these companies do not claim that. The practical challenge remains integration into provider workflows, proof of safety, and the burden of earning clinician trust. In healthcare, the agent economy is real, but it is arriving through documentation and patient operations first, not through unsupervised diagnosis.
Pros
Cons
⚠️ Why adoption is slower here. Healthcare agents can show strong ROI on documentation and outreach, but deployment is gated by safety review, integration work, and clinician trust.
| Company | Recent verifiable data point | Primary workflow |
|---|---|---|
| Hippocratic AI | $53M Series A announced Jan. 2024; $141M Series B announced Jan. 2025 at $1.64B valuation | Patient-facing clinical and operational calls |
| Abridge | $150M Series C announced Feb. 2025 | Ambient clinical documentation |
Finance: research and diligence are the early beachhead
Finance verdict: high ROI, high scrutiny
Finance is a natural fit for agents because so much work is document-heavy, deadline-driven, and expensive in analyst time. The strongest early products are not replacing investment judgment; they are compressing the time it takes to search, synthesize, and prepare materials. Hebbia is one of the best-known examples, positioning its product around AI-powered knowledge work for finance and other enterprise use cases. Endex is focused on automating back-office and operations workflows for financial institutions.
Hebbia announced a $130 million Series B in July 2024 led by Andreessen Horowitz, bringing its total funding to more than $160 million according to the company announcement. That is a meaningful signal that investors believe analyst-style AI workflows can become durable software categories. Endex announced a $10 million seed round in October 2024 led by Lakestar and Lightspeed Faction, with a product focus on financial operations automation.
What appears to be working in finance is retrieval, synthesis, and workflow acceleration over large internal and external document sets. These are tasks where the value of shaving hours off research or diligence is obvious. The challenge is that finance buyers also need permissioning, audit trails, and confidence that outputs are grounded in source material. A flashy answer is less useful than a traceable one.
What is not yet proven publicly is broad autonomous execution across sensitive financial workflows without heavy review. The market is moving, but the pattern looks similar to healthcare: narrow, high-value tasks first. In finance, the agent economy is landing where a system can act like a very fast analyst or operations assistant rather than an independent decision-maker.
| Company | Recent verifiable data point | Primary workflow |
|---|---|---|
| Hebbia | $130M Series B announced July 2024; total funding over $160M per company announcement | Research, search, and synthesis for knowledge workers |
| Endex | $10M seed announced Oct. 2024 | Financial operations and back-office automation |
Legal: contract review and claims are where agents look most practical
Legal verdict: one of the strongest verticals
Legal has become one of the clearest vertical markets for AI agents because the work is overwhelmingly language-based and often repetitive. The companies named most often in the category each attack a different slice of that problem. Harvey is focused on legal and professional services workflows. Robin AI centers on contract review and legal copilot functions. EvenUp applies AI to personal injury case preparation and claims-related work.
The funding numbers are substantial. Harvey announced a $300 million Series D in February 2025 at a $3 billion valuation. Robin AI announced a $26 million Series B in January 2024. EvenUp announced a $135 million Series D in October 2024. Those rounds suggest legal buyers and investors see enough repeatable value in drafting, review, and case preparation to support large category leaders.
What appears to be working is the use of agents as accelerators for structured legal work: reviewing clauses, comparing documents, drafting first passes, and assembling case materials. These are tasks where lawyers already work from precedent, templates, and large document sets. AI can reduce the time to first draft or first review, even if final responsibility remains with a human attorney.
What is not solved is the trust gap around accuracy, privilege, and professional responsibility. Legal work is unforgiving when a fabricated citation, omitted clause, or unsupported claim slips through. That means the practical deployment model is still human-in-the-loop. Legal may be one of the best markets for agent software, but it is also one of the clearest examples of why ‘copilot plus review’ remains more realistic than fully autonomous execution.
📌 Why legal is attractive. Legal work is text-native, precedent-heavy, and expensive in billable time. That makes even partial automation commercially meaningful.
| Company | Recent verifiable data point | Primary workflow |
|---|---|---|
| Harvey | $300M Series D announced Feb. 2025 at $3B valuation | Legal and professional services workflows |
| Robin AI | $26M Series B announced Jan. 2024 | Contract review and legal copilot tasks |
| EvenUp | $135M Series D announced Oct. 2024 | Personal injury case preparation and claims support |
Sales: the busiest market, but also the noisiest
Sales verdict: big demand, uneven quality
Sales is one of the most crowded agent categories because the ROI story is easy to pitch: automate prospecting, enrich accounts, personalize outreach, and book more meetings. The named companies here reflect different approaches. 11x markets AI digital workers for go-to-market teams. Artisan positions itself around AI employees for outbound sales. Clay has become a widely used workflow layer for enrichment, research, and personalized outbound operations.
The funding data shows investor appetite, though the category is still sorting signal from hype. 11x announced a $24 million Series A in September 2024. Artisan announced a $25 million Series A in April 2024 and later announced a $25 million Series A extension in October 2024. Clay announced a $46 million Series B in January 2025. These are meaningful rounds for products aimed at top-of-funnel and revenue workflow automation.
What appears to be working is workflow orchestration more than fully autonomous selling. Clay’s market presence reflects the value of combining data sources, enrichment, and personalization into repeatable outbound systems. Sales teams will adopt tools that help reps target better accounts and move faster. They are less likely to trust a black-box agent to run the entire funnel without supervision.
What is not working consistently is quality at scale. Sales agents run into deliverability issues, weak personalization, brand risk, and compliance concerns faster than many categories. The market is active because the pain point is obvious, but it is also noisy because low-quality automation can create negative externalities quickly. Sales may be one of the largest agent categories by vendor count, yet it is also one of the hardest places to sustain differentiation.
⚠️ Crowded category risk. Sales agents can show fast demos and fast adoption, but poor message quality and deliverability problems can erase ROI just as quickly.
| Company | Recent verifiable data point | Primary workflow |
|---|---|---|
| 11x | $24M Series A announced Sept. 2024 | AI digital workers for go-to-market teams |
| Artisan | $25M Series A announced Apr. 2024; $25M Series A extension announced Oct. 2024 | Outbound sales automation |
| Clay | $46M Series B announced Jan. 2025 | Enrichment, research, and outbound workflow orchestration |
Engineering: the most visible proving ground for agents
Engineering verdict: the clearest early winner
Engineering is where AI agents are easiest to observe because the work happens in software, the outputs are inspectable, and users are technically equipped to evaluate quality. That is why coding agents and AI-native editors have become the public face of the agent economy. Cognition introduced Devin as an AI software engineer, while Cursor from Anysphere has become one of the fastest-growing AI coding products by embedding agentic behavior directly into the editor.
The funding and valuation data is striking. Cognition announced a $175 million fundraise in March 2024 at a $2 billion valuation. Anysphere announced a $100 million Series B in December 2024. In 2025, multiple outlets reported that Anysphere’s valuation had risen sharply; readers looking for the company arc can see our earlier coverage at /cursor-anysphere-timeline-vs-code-fork-to-9-billion/. For Devin specifically, see /what-is-cognition-devin-complete-2026-enterprise-guide/.
What appears to be working is not the fantasy of a fully autonomous engineer replacing a team. It is the practical combination of code generation, codebase search, refactoring, debugging help, and task execution inside a developer workflow. Cursor’s traction reflects that reality: developers want an editor that can understand the codebase, make changes, and stay in the loop with the user. The product category benefits from immediate feedback. If the code is wrong, the compiler, tests, or reviewer will usually say so.
What is not solved is reliability on long-horizon tasks. Agent demos can look impressive on bounded examples, but production software work involves ambiguous requirements, hidden dependencies, security review, and coordination across systems. Engineering is still the lead category because the feedback loop is so strong. It is also the category that most clearly shows the gap between useful agent assistance and dependable autonomous execution.
Pros
Cons
📌 Why engineering leads. Developer workflows are digital, testable, and instrumented. That makes coding agents easier to evaluate, improve, and justify than agents in many other enterprise functions.
{
"sector": "engineering",
"agent_tasks": [
"code generation",
"refactoring",
"debugging",
"codebase search",
"task execution"
],
"why_it_works": [
"digital workflow",
"fast feedback loops",
"measurable output"
],
"main_limitations": [
"long-horizon reliability",
"security review",
"ambiguous requirements"
]
}“Engineering is the sector where agent output can be tested, diffed, reviewed, and shipped—or rejected—within minutes.”
alatirok analysis
| Company | Recent verifiable data point | Primary workflow |
|---|---|---|
| Cognition | $175M fundraise announced Mar. 2024 at $2B valuation | AI software engineering and task execution |
| Cursor / Anysphere | $100M Series B announced Dec. 2024 | AI-native coding editor and codebase-aware assistance |
What the sector data means for the agent economy
The data across these five sectors points to a simple conclusion: the agent economy is becoming real through narrow, workflow-embedded products, not through generalized autonomous workers. Healthcare, finance, and legal show that regulated or high-stakes sectors will adopt agents when the task is constrained and the review model is clear. Sales shows that demand alone is not enough; quality and trust determine whether automation sticks. Engineering shows why developer tools have become the breakout category: the work is observable, the ROI is immediate, and the product can improve from direct user feedback.
For founders, the lesson is that vertical credibility matters as much as model capability. The companies attracting capital are not just wrapping a model. They are packaging workflow knowledge, integrations, safety controls, and user experience around a specific job to be done. For buyers, the lesson is to evaluate agents like software systems, not like magic. Ask what queue, draft, ticket, or task the agent is meant to improve, how performance is measured, and where human review remains necessary.
For investors, the sector split matters because not all agent markets will mature at the same speed. Engineering and sales can scale quickly because deployment friction is lower. Healthcare and legal may produce durable businesses with deeper moats, but adoption will be slower and more trust-dependent. Finance sits in the middle: high-value workflows, strong demand, and a premium on traceability.
That is the current shape of AI agents by industry. The winners are not the loudest claims of autonomy. They are the products that fit into real work, produce auditable output, and earn the right to take on more responsibility over time.
📌 Bottom line. The near-term agent economy belongs to constrained systems with measurable ROI. Sector leaders are winning by owning a workflow, not by promising universal autonomy.
| Sector | Near-term outlook | Why |
|---|---|---|
| Healthcare | Selective growth | Strong ROI in documentation and outreach, slower trust and integration cycles |
| Finance | Steady expansion | Research and operations are valuable targets if outputs stay auditable |
| Legal | Strong vertical momentum | Text-heavy repetitive workflows make review and drafting compelling |
| Sales | Large but volatile | Easy adoption path, but quality and compliance issues create churn |
| Engineering | Fastest visible adoption | Digital workflows and fast feedback loops favor rapid product improvement |
Frequently asked questions
Yes, but mostly in constrained workflows rather than broad autonomous care. Hippocratic AI focuses on patient-facing operational and clinical communication tasks, while Abridge focuses on ambient clinical documentation and note generation integrated into provider workflows.
CB Insights said in April 2025 that AI agent startups had raised $8.2 billion since 2023, with enterprise applications accounting for the largest share in its analysis. See the CB Insights report here: AI Agents Market Map.
Primary sources
- CB Insights AI Agents Market Map — CB Insights
- Hippocratic AI Series A announcement — Hippocratic AI
- Hippocratic AI Series B announcement — Hippocratic AI
- Abridge raises $150M Series C — Abridge
- Hebbia raises $130M Series B — Hebbia
- Endex raises $10M seed — Endex
- Harvey raises Series D — Harvey
- Robin AI raises Series B — Robin AI
- EvenUp raises Series D — EvenUp
- 11x raises Series A — 11x
- Artisan raises Series A — Artisan
- Artisan raises Series A extension — Artisan
- Clay raises Series B — Clay
- Cognition funding announcement — Cognition
- Anysphere raises $100M Series B — Cursor
- Abridge product site — Abridge
- Epic integration mention on Abridge site — Abridge
Last updated: May 20, 2026. Related: Agent Infrastructure.
